PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
IBRN vs. MEDI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between IBRN and MEDI is 0.68, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.7

Performance

IBRN vs. MEDI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Neuroscience and Healthcare ETF (IBRN) and Harbor Health Care ETF (MEDI). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%SeptemberOctoberNovemberDecember2025February
-1.91%
0.73%
IBRN
MEDI

Key characteristics

Sharpe Ratio

IBRN:

-0.09

MEDI:

0.26

Sortino Ratio

IBRN:

0.02

MEDI:

0.49

Omega Ratio

IBRN:

1.00

MEDI:

1.06

Calmar Ratio

IBRN:

-0.11

MEDI:

0.35

Martin Ratio

IBRN:

-0.24

MEDI:

0.70

Ulcer Index

IBRN:

8.02%

MEDI:

6.08%

Daily Std Dev

IBRN:

21.37%

MEDI:

16.18%

Max Drawdown

IBRN:

-30.32%

MEDI:

-12.29%

Current Drawdown

IBRN:

-10.34%

MEDI:

-2.66%

Returns By Period

In the year-to-date period, IBRN achieves a 0.71% return, which is significantly lower than MEDI's 10.80% return.


IBRN

YTD

0.71%

1M

1.78%

6M

-1.91%

1Y

-0.13%

5Y*

N/A

10Y*

N/A

MEDI

YTD

10.80%

1M

8.76%

6M

0.73%

1Y

3.79%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


IBRN vs. MEDI - Expense Ratio Comparison

IBRN has a 0.47% expense ratio, which is lower than MEDI's 0.80% expense ratio.


MEDI
Harbor Health Care ETF
Expense ratio chart for MEDI: current value at 0.80% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.80%
Expense ratio chart for IBRN: current value at 0.47% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.47%

Risk-Adjusted Performance

IBRN vs. MEDI — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBRN
The Risk-Adjusted Performance Rank of IBRN is 66
Overall Rank
The Sharpe Ratio Rank of IBRN is 66
Sharpe Ratio Rank
The Sortino Ratio Rank of IBRN is 66
Sortino Ratio Rank
The Omega Ratio Rank of IBRN is 66
Omega Ratio Rank
The Calmar Ratio Rank of IBRN is 55
Calmar Ratio Rank
The Martin Ratio Rank of IBRN is 66
Martin Ratio Rank

MEDI
The Risk-Adjusted Performance Rank of MEDI is 1313
Overall Rank
The Sharpe Ratio Rank of MEDI is 1212
Sharpe Ratio Rank
The Sortino Ratio Rank of MEDI is 1111
Sortino Ratio Rank
The Omega Ratio Rank of MEDI is 1111
Omega Ratio Rank
The Calmar Ratio Rank of MEDI is 1818
Calmar Ratio Rank
The Martin Ratio Rank of MEDI is 1212
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

IBRN vs. MEDI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Neuroscience and Healthcare ETF (IBRN) and Harbor Health Care ETF (MEDI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for IBRN, currently valued at -0.09, compared to the broader market0.002.004.00-0.090.26
The chart of Sortino ratio for IBRN, currently valued at 0.02, compared to the broader market-2.000.002.004.006.008.0010.0012.000.020.49
The chart of Omega ratio for IBRN, currently valued at 1.00, compared to the broader market0.501.001.502.002.503.001.001.06
The chart of Calmar ratio for IBRN, currently valued at -0.11, compared to the broader market0.005.0010.0015.00-0.110.35
The chart of Martin ratio for IBRN, currently valued at -0.24, compared to the broader market0.0020.0040.0060.0080.00100.00-0.240.70
IBRN
MEDI

The current IBRN Sharpe Ratio is -0.09, which is lower than the MEDI Sharpe Ratio of 0.26. The chart below compares the historical Sharpe Ratios of IBRN and MEDI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00SeptemberOctoberNovemberDecember2025February
-0.09
0.26
IBRN
MEDI

Dividends

IBRN vs. MEDI - Dividend Comparison

IBRN's dividend yield for the trailing twelve months is around 0.39%, less than MEDI's 0.49% yield.


TTM20242023
IBRN
iShares Neuroscience and Healthcare ETF
0.39%0.40%0.05%
MEDI
Harbor Health Care ETF
0.49%0.54%0.66%

Drawdowns

IBRN vs. MEDI - Drawdown Comparison

The maximum IBRN drawdown since its inception was -30.32%, which is greater than MEDI's maximum drawdown of -12.29%. Use the drawdown chart below to compare losses from any high point for IBRN and MEDI. For additional features, visit the drawdowns tool.


-14.00%-12.00%-10.00%-8.00%-6.00%-4.00%-2.00%0.00%SeptemberOctoberNovemberDecember2025February
-10.34%
-2.66%
IBRN
MEDI

Volatility

IBRN vs. MEDI - Volatility Comparison

The current volatility for iShares Neuroscience and Healthcare ETF (IBRN) is 5.29%, while Harbor Health Care ETF (MEDI) has a volatility of 5.84%. This indicates that IBRN experiences smaller price fluctuations and is considered to be less risky than MEDI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


3.00%4.00%5.00%6.00%7.00%8.00%SeptemberOctoberNovemberDecember2025February
5.29%
5.84%
IBRN
MEDI
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab